SNY
Income statement / Annual
Last year (2024), Sanofi's total revenue was $44.29 B,
an increase of 6.41% from the previous year.
In 2024, Sanofi's net income was $5.56 B.
See Sanofi,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$44.29 B |
$41.62 B |
$40.56 B |
$39.18 B |
$37.37 B |
$37.63 B |
$35.68 B |
$36.22 B |
$34.70 B |
$34.86 B |
| Cost of Revenue |
$13.21 B
|
$12.63 B
|
$11.88 B
|
$12.26 B
|
$12.16 B
|
$11.98 B
|
$11.44 B
|
$11.61 B
|
$10.70 B
|
$10.92 B
|
| Gross Profit |
$31.08 B
|
$28.99 B
|
$28.68 B
|
$26.92 B
|
$25.21 B
|
$25.65 B
|
$24.24 B
|
$24.61 B
|
$24.00 B
|
$23.94 B
|
| Gross Profit Ratio |
0.7
|
0.7
|
0.71
|
0.69
|
0.67
|
0.68
|
0.68
|
0.68
|
0.69
|
0.69
|
| Research and Development Expenses |
$7.39 B
|
$6.51 B
|
$6.50 B
|
$5.69 B
|
$5.53 B
|
$6.02 B
|
$5.89 B
|
$5.47 B
|
$5.17 B
|
$5.08 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.18 B
|
$8.93 B
|
$8.74 B
|
$9.56 B
|
$9.39 B
|
$9.88 B
|
$9.86 B
|
$10.07 B
|
$9.48 B
|
$9.38 B
|
| Other Expenses |
$7.25 B
|
$6.59 B
|
$3.28 B
|
$3.55 B
|
-$3.82 B
|
$6.70 B
|
$3.81 B
|
$3.26 B
|
$2.81 B
|
$3.85 B
|
| Operating Expenses |
$23.83 B
|
$22.03 B
|
$18.52 B
|
$18.79 B
|
$11.10 B
|
$22.60 B
|
$19.57 B
|
$18.80 B
|
$17.46 B
|
$18.32 B
|
| Cost And Expenses |
$37.03 B
|
$34.66 B
|
$30.40 B
|
$31.05 B
|
$23.26 B
|
$34.58 B
|
$31.00 B
|
$30.42 B
|
$28.17 B
|
$29.24 B
|
| Interest Income |
$457.53 M
|
$530.50 M
|
$168.96 M
|
$3.13 M
|
$34.43 M
|
$89.71 M
|
$74.37 M
|
$53.97 M
|
$59.03 M
|
$58.01 M
|
| Interest Expense |
$622.58 M
|
$512.82 M
|
$384.80 M
|
$377.37 M
|
$430.84 M
|
$536.28 M
|
$486.48 M
|
$333.43 M
|
$399.50 M
|
$423.38 M
|
| Depreciation & Amortization |
$3.59 B
|
$4.43 B
|
$3.11 B
|
$3.35 B
|
$3.67 B
|
$7.45 B
|
$4.28 B
|
$3.69 B
|
$3.30 B
|
$4.28 B
|
| EBITDA |
$11.03 B |
$11.39 B |
$13.51 B |
$11.54 B |
$17.88 B |
$10.66 B |
$9.18 B |
$9.64 B |
$9.90 B |
$10.08 B |
| EBITDA Ratio |
0.25
|
0.27
|
0.33
|
0.29
|
0.48
|
0.28
|
0.26
|
0.27
|
0.29
|
0.29
|
| Operating Income Ratio |
0.16
|
0.17
|
0.25
|
0.21
|
0.38
|
0.08
|
0.13
|
0.16
|
0.19
|
0.16
|
| Total Other Income/Expenses Net |
-$494.00 M
|
-$845.00 M
|
-$170.00 M
|
-$289.00 M
|
$24.00 M
|
-$44.00 M
|
$228.00 M
|
-$188.00 M
|
-$720.00 M
|
-$403.00 M
|
| Income Before Tax |
$6.76 B
|
$6.12 B
|
$9.99 B
|
$7.84 B
|
$14.14 B
|
$3.01 B
|
$4.90 B
|
$5.62 B
|
$5.81 B
|
$5.22 B
|
| Income Before Tax Ratio |
0.15
|
0.15
|
0.25
|
0.2
|
0.38
|
0.08
|
0.14
|
0.16
|
0.17
|
0.15
|
| Income Tax Expense |
$1.20 B
|
$1.02 B
|
$1.91 B
|
$1.56 B
|
$1.81 B
|
$121.00 M
|
$481.00 M
|
$1.72 B
|
$1.33 B
|
$709.00 M
|
| Net Income |
$5.56 B
|
$5.40 B
|
$8.37 B
|
$6.22 B
|
$12.29 B
|
$2.75 B
|
$4.31 B
|
$8.42 B
|
$4.71 B
|
$4.29 B
|
| Net Income Ratio |
0.13
|
0.13
|
0.21
|
0.16
|
0.33
|
0.07
|
0.12
|
0.23
|
0.14
|
0.12
|
| EPS |
2.19 |
2.15 |
3.19 |
2.49 |
4.91 |
1.14 |
1.73 |
1.5 |
1.83 |
1.64 |
| EPS Diluted |
2.19 |
2.15 |
3.18 |
2.49 |
4.91 |
1.14 |
1.73 |
3.36 |
1.83 |
1.64 |
| Weighted Average Shares Out |
$2.50 B
|
$2.50 B
|
$2.50 B
|
$2.51 B
|
$2.51 B
|
$2.50 B
|
$2.49 B
|
$2.51 B
|
$2.57 B
|
$2.61 B
|
| Weighted Average Shares Out Diluted |
$2.50 B
|
$2.51 B
|
$2.50 B
|
$2.51 B
|
$2.51 B
|
$2.50 B
|
$2.49 B
|
$2.51 B
|
$2.57 B
|
$2.61 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
